Sonova Holding (OTCMKTS:SONVY) Given Consensus Rating of “Hold” by Brokerages

Shares of Sonova Holding (OTCMKTS:SONVY) have been assigned a consensus recommendation of “Hold” from the nine ratings firms that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a sell rating, four have assigned a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company.

Several equities research analysts recently commented on SONVY shares. Rothschild Redb raised shares of Sonova from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Zacks Research cut shares of Sonova from a “hold” rating to a “strong sell” rating in a research note on Tuesday, December 9th. Royal Bank Of Canada upgraded shares of Sonova to a “moderate buy” rating in a research report on Tuesday, November 18th. Finally, BNP Paribas initiated coverage on Sonova in a report on Monday, October 20th. They issued an “underperform” rating on the stock.

Sonova Price Performance

Shares of SONVY stock opened at $52.38 on Friday. Sonova has a 1-year low of $47.55 and a 1-year high of $71.50. The company has a quick ratio of 0.91, a current ratio of 1.24 and a debt-to-equity ratio of 0.51. The stock has a 50 day simple moving average of $51.58 and a 200-day simple moving average of $55.39.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.